chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Additional Details: Did not have to administer Epipen.  Her throught/tongue swelling was a 3 out of 10.  We called 911.  EMS examined her and left with no treatment.  They advised that she take benadryl and there were no other dangers.
Patient fainted and fell down from the chair in the vaccination waiting area following first dose of Covid-19 vaccine . Syncope(fainting) , Fall from chair, : Paged "Code White", called store management over, Cleaned wound and blood with alcohol, have her drink water, have patient rest until she felt normal. Advised patient to take Tylenol or Advil for pain.  Called to verify if patient was ok next day . Called Supervisor and spoke to pharmacy manager regarding the event . Reported the event into center System.
Fever up to 99.4 degrees, nausea, muscle aches, sleepiness, large red area around the vaccine location which was warm to the touch, soreness at vaccine location. Symptoms most acute for 2 days following the vaccine, then started getting better on the 3rd day, almost completely gone by the 4th. The symptom that was most persistent was the large red area around the vaccine location - it continued to be warm to the touch until the end of the 3rd day.
This spontaneous report as received from a nurse refers to a patient of unknown gender and age. No information regarding the patient's pertinent medical history, concomitant medications and drug reactions or allergies was reported. On 27-MAY-2015, the patient was vaccinated with an expired dose of MMR II, HSA, 0.5 ml, subcutaneously (lot # J006185 and expiration date 24-MAY-2015). No adverse events were reported. No further information was available. Additional information has been requested.
Patient called pharmacy on 2/8/2010 reporting she was getting a rash at the injection site (about penny size). No other adverse reaction reports. Advise patient to take BENADRYL OTC.
1st Event:  Blood started streaming from my nose while I was eating supper.  It drenched paper towel after paper towel in rapid succession. Went to bathroom to stand over sink while pinching the very end (soft part) of my nose.  Blood continued to come through my nose onto paper towel and back up in my nose and simultaneously stream from my mouth.  When I released my pinch to clear my nose, blood streamed out.  Early on, a large puddle the consistency of loose pudding came out and stayed in a large puddle in my sink.  It maintained it form w/o any slow seeping down the sink.  After 30 minutes approx. of blood streaming, I manage to call the 24-hour nurse who stayed on the phone with me for almost 2 1/2 hours until I could tell her the streaming might be very, very slightly slowing.  Meanwhile she was telling me I would have to go to medical facility if it didn't stop.  After 3 hours it did start to slow down though still flowing from my mouth and nose.  Finally it stopped and then I started passing very large clots from my mouth.  11:00 pm was when the last clot passed.  Total time from 5:30 pm until 11:00 pm.  2nd event was 11-19-21:  7:00 a.m. blood started drippin from my nose.  I pinched my nose and after about 4 minutes, it stopped.  3rd event was 12-1-21:  5.45 a.m.  I was lying in bed awake and all of a sudden I felt like I needed to blow my nose.  I got up and saw blood soaking my pillow, bed linens, etc.  This lasted until 9:00 a.m. when I passed the last clot through my mouth.  Bleeding streamed from before 5:45 a.m. until about 8:30 a.m.
10 days after my first dose I have a ~3.5" diameter oval red spot on my arm at the spot of injection. It is slightly itchy and a little tender to the touch. Not painful though.
Patient felt fatigued, nauseated, and felt faint.  Ambulance took her to ER.  Physician determined symptoms were consistent  with covid vaccination.
patient complained of chest pain 15 minutes after vaccine administration. Patient has new onset cough variant asthma. We administered a nebulizer treatment and the pain subsided, although patient never had any wheezing noted.
Symptoms included, nausea, chills, fever, diarrhea, and fatigue
just felt kind of lazy; She states it is just enough pain to keep her awake at night; pins and needles; shoulder pain; whole right arm and into her hand it is completely asleep all of the time; At the injection site, she still has the side effects, it is very painful in her right arm, the whole right arm; This is a spontaneous report from a contactable consumer. This 73-year-old female patient (consumer) reported for herself that: A 73-year-old female patient received bnt162b2 (COMIRNATY), via an unspecified route of administration, administered in Arm Right on 25Feb2021 08:15 (Lot Number: EL9266) (at the age of 73-year-old) as DOSE 2, SINGLE for COVID-19 immunization. Medical history included fibromyalgia which had for about 20 years, plaque shift, sleep disorder. The patient previously took BNT162B2 (first dose, lot number: EL3247) administrated in arm left on 03Feb2021 (at the age of 73-year-old) for covid-19 immunization. Concomitant medications included lisinopril (LISINOPRIL) 0.5mg once a day, in the morning taken for plaque shift; alprazolam (XANAX) (NDC, LOT, EXP unknown) 1 mg and upped to 2mg 6 months ago taken for sleep disorder. The patient experienced very painful in her right arm (at the injection site) on 27Feb2021 with outcome of not recovered; felt kind of lazy, awake at night, felt pins and needles, shoulder pain, Movement disorder on an unspecified date with outcome of unknown. Patient took Tylenol every once in a while during the day if pain got really bad. Vaccination site pain required a physician office visit. Patient stated that she did not had other additional vaccines on the same date of the Pfizer vaccine and no prior vaccinations. No follow-up attempts are possible. No further information is expected.
thick yellow mucous/she coughed and produced thick yellow mucous; coughed and produced thick yellow mucous; allergic reaction; This is a spontaneous report from a contactable consumer (patient). This female patient of unspecified age received BNT162B2 (PFIZER BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 25Feb2021 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient may have experienced an allergic reaction. The allergic reaction was clarified as the patient coughed and produced thick yellow mucous. The outcomes of allergic reaction and coughed and produced thick yellow mucous was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
Patient says she has sporadic periods. She Said she has not had one in about 2 months. She said she was feeling achy before the vaccine and thinks one may have been imminent. The night after they vaccine she said she woke up with heavy bleeding.  She said it was abnormally heavy and said it will not stop. She said she is also said she has a headache and injection site pain. I recommended she go to a walk in clinic or ER if the blood loss was sufficient and to follow up with her md on Monday. As of now she has not sought medical treatment.
Got mine still got flu; Initial information received on 30-Nov-2020 regarding an unsolicited valid non-serious case received from a consumer (patient) via social media.  This case involves patient (unspecified gender and age) who still got flu (influenza), while he/she received vaccine INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.   On an unknown date, the patient received INFLUENZA VACCINE [lot number: unknown and expiration date: unknown] at an unknown dose via unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, (latency: unknown) after starting the suspect vaccine therapy, patient still got flu (influenza) (non-serious).  No laboratory data was reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information available regarding batch number in this case.
Pt presented with symptoms of UTI along with dry cough, SOB, and fever.  CXR showed lingular pneumonia.  Pt did not require oxygen on admission.  Pt discharged on levofloxacin (to complete 5-day course).
Onset of red bumps that evolved into vesicles 06/21/05. Fever. Vesicles itchy.
Patient received second COVID-19 vaccine on 06/06/2021 and on the next morning  of 06/07/2021 she woke up with a headache, large swollen bump on her left axillary that was red, warm and painful to touch and no fever.
Case number PHEH2014US000892 is an initial spontaneous report received from a health care professional on 08 Jan 2014. This report refers to a female patient of unknown age. She received only Men A lyophilized conjugate component of MENVEO (batch number: not reported), without reconstituted with MenCYW-135 liquid component, intramuscularly on an unknown date in Oct 2013. No adverse reaction reported following this administration error.
Patient hospitalized after being found unresponsive at home.  Admitted with sepsis, COVID, UTI, acute encephalopathy, acute respiratory failure. Intubated for 3 days, could not protect airway, not because of COVID. IV fluid resuscitation, MSSA in blood. Mentation improved. Respiratory status improved, wearing 2-3 L nasal cannula after extubation. ID recommended 4 weeks of antibiotics. PICC line placed.
Information has been received from an office manager on 17-JUL-2008 concerning a 9 year old female patient who on an unspecified date was vaccinated with the first dose of GARDASIL and on 14-NOV-2007 was vaccinated with the second dose of GARDASIL and "is sick".  Specific symptoms unspecified.  The patient sought medical attention, by phone and was coming into the office on 18-JUL-2008.  At the time of the report the patient was not recovered.  The patient's sibling with the same initials also had an adverse experience after vaccination with GARDASIL.  (WAES # 0807USA03678).  Additional information has been requested. This is in follow-up report (s) previously mentioned on 8/14/2008. Follow-up information has been recieved from the physician, who reported that the patient, went to the office to received her third dose of GARDASIL and was "sick" per parents - left without  being seen and returned for third dose at a later date. Her second dose had runny nose and fever in July 2008 were related to the vaccine. Eight months lapsed between the second dose and illness. No additional information is expected.
This spontaneous report has been received from a pharmacist and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history and drug reactions or allergies was provided. n an unknown date, the patient was vaccinated with a dose of ZOSTAVAX injection (dose, lot number, expiration date and route of administration were not reported), which was reconstituted with sterile water diluent. The patient was on immunosuppressive therapy with tacrolimus and everolimus at the time of vaccination. No adverse effects were reported. No product quality complaint was involved. Additional information has been requested.
Patient was given PENTACEL when she should have been given KINRIX there was no adverse reaction but the wrong vaccine was administered.
Pain began hours after injection.  Morning after site was red, swollen, 24 hrs after red swollen area spread.  36 hrs entire upper arm swollen, red, tender, and skin hot.
We had a 14 year old female who had a Vasovagal syncope episode in the outpatient pharmacy after a booster dose of Pfizer was administered to her.  We called a rapid response team after assessing the child when the parent reported that the patient was feeling dizzy and upon examination had also turned very pale.  We provided a snack, water, and Pedialyte to the patient before she was taken to the ER.  Patient was discharge from the ER later in the afternoon.   BP 101/68, Pulse 64, Temp 36.8 C, Resp 18, SpO2 99%.  ED discharge diagnoses was Vasovagal episode after vaccination and dehydration.
About 40 min after my shot I started feeling tightness (like asthma) in my chest. I ended up needing 6 puffs from my inhaler. (I had also experienced feeling very agitated throughout that day and night). The periodic daily need for the i hailer continued and so I called Moderna and the woman I spoke with told me that the breathing issue was a reaction (she was not as sure about the feeling of agitation) and that when I got my second dose to have them observe for an hour. Over the weeks since that first breathing episode it has continued daily and required the use of my in hailer. In the last few days it has been worse than before and I?ve had a mild headache for about 3 days.  Tomorrow is my shot. I didn?t realize about reporting here until I read about it today.  Since I have a n old history of asthma (though it?s been a relative ?non issue? for years (except  when I get a cold in my chest), but I would want this known for other people with asthma, because it?s definitely going on and strange. (Nothing preventing me from my normal day - but for sure my days have not been ?normal?.  I plan on seeing my doctor to get new medicine for the nebulizer and  likely stronger type asthma medication until it goes away)
Cellulitis of left arm.   12/31/09:  Discharge summary and hospital records received for dates of service 12/27/09 to 12/29/09 Dx:LUE Cellulitis, DMI (Uncontrolled), HTN, HLD, hypothyroidism, obesity  Given pneumovax and seasonal flu shot, the next day he felt chills, nausea and a local reaction around the injection site.  The area became progressively more tender, red, swollen and warm to touch.  It extended down the forearm and up into the shoulder.  Notes pain of arm with movement.  Started on IV antibiotics.  Arm continued to improve over course of admission, on day of discharge doing well with no complaints.
Information has been received from a liscensed practical nurse concerning a 5 year old female who on 23-JAN-2004 was vaccinated with varicella virus vaccine live (Oka/Merck). within the last week (February 2007), the patient experienced a breakthrough with the varicella virus vaccine live. The patient developed more than 50 lesions three years after getting the varicella virus vaccine live administered to her. The outcome of the breakthrough was not provided. There was no product quality complaint. unspecified medical attention was sought. Additional information has been requested.
Just under 48 hours after being vaccinated I started having mild chest pain and recurring intense heart palpations that would knock the breath from me. Currently,  this is still happening every few minutes. This has not happened to me before
Legs were elevated & ice pack applied behind neck. Approx. 8mins after vaccine administration, mother notified me that the pt. stated that she felt like she was going to faint & was dizzy. I noticed the pt. in the chair shaking, eyes were rolling back and appeared pale. EMS called by this nurse. Once she became conscious & alert x3 glucose was given by another nurse & V/S were taken. Pt. complained of being cold. EMS arrived & evaluated pt. Sent home with mother.
abrupt onset of widespread, symmetric erythematous eruptions 1-2 hrs p/vax;
urinary tract infection; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (urinary tract infection) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     Concurrent medical conditions included Cancer (She had the cancer for 4 years now).    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced URINARY TRACT INFECTION (urinary tract infection). The patient was treated with DOXYCYCLINE for Urinary tract infection, at an unspecified dose and frequency. At the time of the report, URINARY TRACT INFECTION (urinary tract infection) had not resolved.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       Cancer drug was reported as concomitant medication. It was reported that patient had been taking cancer drugs for 4 years now.  Patient received the Cancer diagnosis before receiving any Moderna vaccine. Patient experienced a urinary tract infection that her Health care professionals were not being able to resolve. Patient mentioned that they tried to treat it with many antibiotics and she was right now taking doxycycline and a cancer drug.
"pt recv vax 31JAN97 & 1FEB97 t101.9, rt deltoid area red, warm, sl edema from elbow area to deltoid, gen malaise;no c/o SOB or hives;encouraged pt to use APAP PRN, heat/cold compresses;"
Information has been received from a certified medical assistant (C.M.A.) concerning a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not reported. On 12-FEB-2015, the patient was vaccinated with a dose of improperly stored PROQUAD (Merck), lot # K014798, expiration date 12-MAR-2016 (dose and route not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected because the physician did not wish to be contacted.
Injection site reaction - Redness, tenderness, and soreness in Left upper deltoid.
Pt given PNEUMOVAX instead of FLUZONE HD by mistake. Pt had PNEUMOVAX 1 week prior. No RXN or problems. Caught immediately after gave shot.
I received the vaccine on 11/13/06 at 11:15 AM. About 8 hours later I began to feel a slight sore throat and earache.  However, at about midnight I developed a severe anxiety attack and depression, which lasted for about 7 hours.  It was accompanied by a very low (96.8) temperature and chills. All of the symptoms subsided by about 8:00PM on November 14.
Day of vaccine: headache, sore arm. Day 2: migraine, eyes sore to touch, burning, extremely sensitive to light, dizzy, extremely tired. Day 3: headache, nausea, vomiting, diarrhea, dizzy, resting heat rate above 100, exhaustion. Day 4: shaky, dizzy, nauseous, resting heat rate not below 100 for several hours, heart palpitations, heart beating very hard at times, exhaustion.
I started having headaches, cough, congestion, fatigue, nausea and I was given over the counter medicine and increase in Vitamin D and C. I still have a lingering cough but I have somewhat recovered.
pain, swelling, redness at site of injection. Fever 102.3 with chills, glands in RT neck beginning to swell.
no additional AE/PQC at time of call; VAQTA was dosed to a patient past the labeled expiry; This spontaneous report as received from a medical assistant concerning a patient of unknown age and gender. There was no information about the patient's medical history, concurrent conditions or concomitant medication.  On 07-JUN-2021, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated(VAQTA) prefilled syringe reported as "past the labeled expiry" ,  dose: 1 milliter, lot # T008698,expiration date: 04-JUN-2021  for prophylaxis  (dose number, and route of administration were not reported).  The reporter stated that it was not known temperature excursions, no additional adverse event reported. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T008698; expirationdate: 04-JUN-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability
Rash developed on chest. Red, not raised, slightly itchy but not severe. A flushed red rash. Took 25mg of chewable Benadryl and it subsided. 2 hours later right ear became red, hot, and itchy. A few raised bumps appeared on top of ear, slightly itchy. Sore arm at injection site but no other complaints at this time.
Immunization at 11:30 am.  Gave Tylenol at 15:00.  Noticed redness at 19:00.  07/11/03, seen at office with 11cm by 8 cm red, warm induration.  Instructed to take Tylenol as needed for discomfort and warm compress.  Return to clinic as needed if symptoms are high.
Systemic: Numbness (specify: facial area, extremities)-Medium, Additional Details: Pain and numbness began shortly after patient received booster dose of Pfizer in left arm (whole arm). After a short period (day), it began developing in right arm as well.
Patient was seen today for 1st pfizer vaccine. parents were instructed to hold the child. during the vaccine administration, child moved his arm and did not receive full dose. RN's & MOD were alerted. Patient is okay with no injuries. Per CDC guideline, the patient is to wait 21 days before attempting to repeat 1st dose again. Parents are aware of the situation and rescheduled a new appointment in 3 weeks.
Left arm cellulitis. Began 24 hours later w/ temp to 102. at 48 hours, redness spreading.
Loud ringing in ears developed about two weeks after the first Pfizer Covid vaccine shot and has not gone away since.
Received the Moderna Monovalent Booster instead of the bivalent vaccine; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (Received the Moderna Monovalent Booster instead of the bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Received the Moderna Monovalent Booster instead of the bivalent vaccine) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Received the Moderna Monovalent Booster instead of the bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Received the Moderna Monovalent Booster instead of the bivalent vaccine).    Concomitant product use was not provided by the reporter.  The nurse stated that it happened because of the monovalent vaccine with the purple border was labeled booster doses.  Treatment information was not provided.
On Saturday 7/14 noticed itchy spots to back (approx 5) and to R knee area (2).  Also site was red, swollen and raised ~2 inches.  No s/s of infection.
Patient experienced pain under the injection site for 3 days. The pain then proceeded to travel down to her elbow and has been consistently painful despite patient taking Tylenol and Aleve and applying heat to the area. She states she can't lift her arm without excruciating pain.
chilles, hot red itchy bumpy rash on stomach and chest also the neck. rash is on left shoulder too